All news

Wall Street Zen downgrades Merck to Hold

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Wall Street Zen downgraded Merck & Co. (NYSE:MRK) from Buy to Hold, even as the broader analyst consensus stays at Moderate Buy. The company posted quarterly revenue of

Read original source

MRK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.